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Abstract
The investigation of immune senescence has uncovered many changes in B cell development, 
maintenance, and function with increasing age. However, most of these studies have focused on 
conventional B cell subsets in the spleen. The B-1 cell subset is an essential arm of the innate 
immune system, which in general has been understudied in terms of immune senescence. Here, we 
review what is currently known about B cells during aging and go on to describe why B-1 cell 
biology is an important component of the aging immune system in the context of diseases that 
most affect the aged population.
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Introduction
The global life expectancy is rapidly increasing. In the year 2000, there were 605 million 
people aged 60 years and over, and by the year 2050 the World Health Organization (WHO) 
predicts that this age group will reach 2 billion. Numerous diseases are associated with 
increased age, including heart disease, cancer, stroke, Alzheimer’s disease, diabetes, 
influenza, and pneumococcal infection.1 The immune system plays a central role in many of 
these diseases. In order to decrease the burden of disease as our population ages, it is 
necessary to understand changes within the immune system with increasing age. In 
particular, B cells play both adaptive and innate roles in diseases of the aged, which is the 
focus of this article. Herein we will first review what is known about conventional B-2 cells 
in the aged immune system, and then discuss the importance of widening our understanding 
of the role B-1 cells play in two primary diseases of the elderly, Streptococcus pneumoniae 
infection and atherosclerosis.
S. pneumoniae is the most common cause of pneumonia.2 In the United States alone, 40,000 
people die each year from pneumococcal infection.2 The incidence of pneumococcal 
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infection and the mortality rate increase dramatically in people over the age of 65, moving 
from an average mortality rate of 0.92 in ages 5–49 to 6.7 in people over the age of 65.3 
These numbers clearly reveal an alarming disparity between the two age groups, despite the 
availability of a vaccine, PPSV23, approved for adults 65 years of age and older since 
1983.2 Postvaccination antibody titers are the same in young adults (under the age of 45) 
and elderly adults (over the age of 65); however, the elderly population contains antibodies 
less effective at clearing bacteria.4 These data clearly demonstrate that pneumococcal 
infections still pose a great challenge in prevention and treatment, particularly in the elderly 
population, which immunization and B-2 cell adaptive immunity have not been able to 
overcome.
Atherosclerosis is the number one cause of death globally, and its incidence increases 
greatly in persons aged 65 and over.5 Blockage of arterial walls and subsequent rupture of 
plaques causes heart attacks and strokes. Inflammation of the arterial wall endothelium leads 
to arterial wall thickening and consequently plaque formation.6 The main cause of this 
inflammation is increased levels of modified serum low-density lipoproteins (LDL), which 
become trapped in the arterial wall.6 LDL is more antigenic after it becomes oxidized 
(OxLDL), and this occurs once in the arterial wall.6 Remarkably, many studies have shown 
that anti-OxLDL antibodies, B-1 cells, and B-1 cell–derived natural IgM are protective 
against atherosclerosis.7,8 However, it is not completely understood how these antibodies 
and/or B-1 cells are maintained throughout adult life. In order to maintain protection against 
atherosclerosis, it is essential to understand how to maintain these protective antibodies with 
increasing age.
When optimizing vaccination strategies, enhancing passive protection, and/or developing 
other treatments for mitigating pneumococcal infection and/or providing protection against 
atherosclerosis, considering the roles of B lymphocytes is of great importance. B cells 
produce antibodies that fight infection by (1) binding pathogens, thereby preventing them 
from infecting host cells; (2) neutralizing toxins; (3) opsonizing pathogens; or (4) activating 
complement, which coats pathogens and leads to opsonization and/or lysis. B cells also 
function as antigen-presenting cells.9 Various subsets of B cells have been defined in both 
mice and humans by their distinct phenotypic and functional characteristics. This brief 
review will focus on murine B cells during aging, as aging of human B cells has been 
reviewed elsewhere.10 In the mouse, these subsets include B-2 cells, which comprise 
follicular (FO) and marginal zone (MZ) B cells found mainly in the spleen, and B-1 cells, 
which include B-1a (CD5+) and B-1b (CD5−) cells found in the spleen, peritoneal cavity, 
bone marrow (BM), and pleural cavity. Together, these B cell subsets provide immediate 
(B-1 cells) and long-lasting (B-2 cells) protection against infection, whereas natural IgM and 
B-1 cells provide protection from atherosclerosis.
Numerous studies have elucidated the age-related changes affecting conventional B-2 cells. 
These changes occur from the earliest developmental stages throughout maturity. Going 
forward, this extensive knowledge about B-2 senescence will be extremely valuable in 
advancing the knowledge about B-1 cell senescence, which is currently limited.
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B cells in the aging immune system: development, maintenance, and 
function
B cell development in the aging immune system
B cell development begins with hematopoietic stem cells (HSCs). HSCs are self-renewing 
pluripotent cells found in fetal liver and adult BM, which have the ability to give rise to all 
blood cells.11 B cell development continues through a series of differentiation steps dictated 
by expression of transcription factors, cytokines, and cell surface receptors. Proper 
immunoglobulin rearrangement allows the B cell to progress through critical stages of 
differentiation, culminating in a naive B cell expressing a B cell receptor (BCR), which is 
necessary for B cell survival and response to antigen12 (Fig. 1). Each stage of B cell 
development is marked by specific gene and surface marker expression [13, 14]. During 
immunoglobulin rearrangement, non-templated (N) nucleotides can be added to the joins of 
gene segments, which increases diversity of the receptor.15 B-2 cell development continues 
throughout life in the BM of adult mice from specific B220+CD19− B cell progenitors.16 
Conversely, the B-1 cell population originates mainly during fetal life and was thought to 
persist throughout adult life only by self-renewal.17. Only recently, Dorshkind and 
colleagues identified a B-1 cell–specific progenitor, Lin−CD45lo/−CD19+, found in low 
numbers in the adult BM and abundantly in the fetal liver.18 Due to the recent understanding 
that B-1 cell progenitors are present in adult BM, little is known about how aging affects 
B-1a cell development and/or maintenance. However, B-2 cell development in the aged 
immune system has been shown to be impaired as a result of both intrinsic and extrinsic 
factors.
First, we will discuss the effects of aging upon HSCs, which is where B cell development 
begins. The number of HSCs has been shown to increase with age, do functional defects 
including self-renewal and homing defects.19 Despite the increase in number, transfer 
experiments demonstrate that HSCs from aged mice are less effective at generating both B 
and T cells as compared to young mice, (reviewed in Ref. 20). Interestingly, transferring 
aged whole bone marrow (WBM) into young recipients generates the same frequency of B 
cells as transferring WBM from young donors.21 However, when HSCs were purified from 
BM of aged donors and then transplanted into young recipients, B cells are not readily 
detected.22,23 These seemingly contradictory results have been hypothesized to be due to 
age-related changes in the surface phenotype of HSCs23 and cell-intrinsic defects related to 
homing.21 Different phenotypic subsets of HSCs have been described (reviewed in Ref. 19). 
It is possible that the different subsets’ surface phenotypes change with age, which could 
alter reconstitution results upon purification of certain HSC subsets owing to loss or 
exclusion. WBM, on the other hand, would contain all subsets of HSCs regardless of 
changes in surface phenotype. Interestingly, these studies also revealed an increase in 
myeloid differentiation from aged WBM21 and purified HSCs.22 It was subsequently shown 
that HSC potential for myeloid or lymphoid differentiation can be divided by CD86 
expression (CD86−CD150+ and CD86+CD150+, respectively), and the HSCs with myeloid 
potential were increased in aged BM whereas the HSCs with lymphoid potential were 
reduced.24 Together, these studies demonstrate changes in aged HSCs, which could lead to 
further alterations seen in B cell development in the BM.
Holodick and Rothstein Page 3









The next steps in development from HSCs to a committed B cell progenitor are also 
associated with changes during aging. HSCs first develop into non–self-renewing 
multipotent progenitors (MMP), followed by lymphoid-primed multipotent progenitors 
(LMPP), early lymphoid progenitors (ELP), common lymphoid progenitors (CLP) (which 
are also called early B cell precursors (EBP)), and then progress to pre-pro B cells23,25 (Fig. 
1). Commitment to the B cell lineage is dependent upon expression of a number of 
transcription factors, including Ikaros, Pu.1, E2A (E12/E47), EBF (early B cell factor), and 
PAX-5.23 In particular, E2A and EBF act together to direct CLPs toward B cell 
commitment, and, as will be described herein, also have other significant roles throughout B 
cell development.26 E2A plays a role in the commitment of both MPPs and LMPPs to 
lymphoid versus myeloid lineages;26 however, the effect of aging upon E2A expression and 
function in MMPs or LMPPs has not yet been studied despite the age-related decrease in 
these populations.27 A decrease in the number of CLPs has also been observed in aged 
mice,27,28 as well as a decrease in the number of pro-B28 and pre-B cells29 found in the BM 
of aged mice. It was proposed that the decrease in early B cell precursors results from 
defects in transcription regulated by E2A/EBF proteins,27,30,31 which aid in early B cell 
specification and differentiation from MMPs, LMPPs, and CLPs to pro-B cells.26 This 
hypothesis is supported by the findings that both stem cells and CLPs from aged mice have 
reduced potential to produce B cells, and Ebf1 is reduced in CLPs from aged mice, which, if 
restored, can reestablish B cell generation from aged CLPs.27 These results demonstrate that 
cell-intrinsic defects affect aged CLPs and early stages of B cell differentiation. However, it 
has also been shown that cell-extrinsic defects or BM microenvironment defects also play 
roles in age-related changes leading to a decrease in pro- and pre-B cell numbers in the aged.
Interestingly, both cell intrinsic and extrinsic defects affect the early stages of B cell 
development. IL-7 receptor α chain (IL-7Rα) expression is first seen in the CLP stage. IL-7 
is secreted by BM stromal cells and is necessary for the survival and continued development 
of FO B-2 cell progenitors. However, IL-7 is not necessary for MZ B cells or B-1 cell 
progenitors, whereas the IL-7Rα chain is necessary for all B cell subset progenitors.32 Early 
in the CLP stage, IL-7 signaling is necessary for the induction of the transcription factor 
EBF1, which is required for initiation of immunoglobulin gene rearrangement and therefore 
differentiation into the pre-pro-B cell stage of development.26,33 It has been shown that aged 
pro-B cells have an impaired ability to respond to IL-7 despite the normal expression level 
of IL-7R.34 Interestingly, transfer of aged BM into young recipients yielded numbers of pre-
B cells seen in young mice; however, transfer of young BM into aged recipients yielded a 
decrease in the numbers of pre-B cells, which are normally observed in aged mice.35 These 
results point to a defect in the BM microenvironment. Along these lines, it has been 
demonstrated that BM stromal cells from aged mice are defective in releasing IL-7.34 
Furthermore, BM stromal cells from aged mice increase the production of the chemokine 
RANTES, which promotes myeloid differentiation and inhibits lymphoid differentiation.36 
These studies clearly demonstrate that extrinsic factors play a role in age-related changes in 
B lymphopoiesis.
The roles that cell-intrinsic defects play in the loss of pro-B and pre-B cells in the aged have 
been studied extensively. The pro-B cell stage of development is initiated by the assembly of 
the BCR, which begins with homologous recombination of germline heavy chain genes to 
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form the variable region and continues through the pre-BII stage where homologous 
recombination of the light chain genes occur (reviewed in Ref. 37). The variable region of 
the heavy chain comprises three gene segments: variable (V), diversity (D), and joining (J), 
whereas the light chain comprises two: (V) and (J). Rearrangements of these segments are 
regulated by recombination signal sequences (RSS), which flank the segments. In addition, 
the RSS serves as the binding site for the proteins RAG-1 and RAG-2, which once bound to 
each RSS cleave the DNA between the coding sequence and RSS. After cleavage by RAG-1 
and RAG-2, the coding ends remain as hairpin loops that are opened by the Artemis–DNA-
PK complex. The opening of the coding ends by Artemis–DNA-PK sometimes results in 
palindromic DNA sequences, referred to as P-nucleotides. Next, non-templated nucleotides 
(N-nucleotides) are added to the single stranded ends of the hairpins by the enzyme terminal 
deoxynucleotidyl transferase (TdT). Finally, DNA repair enzymes remove unpaired 
nucleotides and the two single stranded coding ends are ligated. It has been shown that both 
Rag2 and recombinase activity are decreased in pro-B cells of aged mice,35 which would 
decrease the pre-B cell pool. E2A expression is also decreased in pro-B cells from aged 
mice,27,30,31 which contributes to decreased expression of Pax-5 and increased turnover of 
Pax-5.38 Pax-5 expression is required for B cell progenitors to remain committed to the B 
cell lineage throughout development through repression of non-B lineage genes in pro-B 
cells.39 These results demonstrate that, in addition to the cell-extrinsic defects described 
above, cell-intrinsic defects present in aged pro-B cells also lead to decreased numbers of 
pro-B cells in aged mice. Similar results have been shown for pre-B cells.
Once pro-B cells finish assembly of the heavy chain, they enter the pre-B cell stage. At this 
stage, the rearranged heavy chain pairs with VpreB and lambda 5, which together make up 
the surrogate light chain and is regulated by E2A and EBF1.40 Rearrangement of the light 
chain (V) and (J) regions occurs in the pre-BII stage. In light of the fact that E2A is 
decreased in aged pro-B cells and regulates transcription of the surrogate light chain genes, 
it is not surprising that aged pro-B/early pre-B cells show reduced surrogate light chain 
expression, which consequently leads to reduced pre-BCR expression.31 It has been 
suggested that low surrogate light chain expression can lead to a more autoreactive 
repertoire, due to a less stringent pre-BCR checkpoint.41 In fact, serum autoantibodies have 
been shown to increase with age.42 E2A and EBF1 also promote transcription of RAG 
genes, which are required during both pro-B and pre-B cell development.26 Overall, these 
studies demonstrate that E2A, EBF1, and Pax-5 play central roles in the reduced number of 
pro and pre-B cells in aged mice.
It is not known to what extent the aged BM environment contributes to these observed 
defects; however, IL-7 signaling is necessary for Ebf1 induction, yet BM stromal cells are 
defective in releasing IL-7. Furthermore, mature B cells in the periphery of aged mice have 
been shown to affect B lymphopoiesis. Increased longevity of peripheral mature B cells in 
aged mice43 has recently been shown to play a role in the reduced numbers of B cell 
progenitors. This study eloquently demonstrated that depletion of mature B cells lead to an 
increase in pro-B cells, pre-B cells, MMPs, and CLPs.44 It has been further hypothesized 
that, owing to the increased longevity of mature peripheral B cells, there is a decrease in the 
need for B cell generation, which HSCs sense and which leads to their increased myeloid 
Holodick and Rothstein Page 5









potential.45 Together, these studies indicate that aging has far-reaching effects upon B cell 
development; from the earliest stem cells, to committed lymphoid progenitors, to committed 
B cell progenitors, and even to the longevity of mature B cells, which in turn has 
consequences for early B cell development (Fig. 2). However, further investigation is 
required to elucidate how the interplay between cell-extrinsic and cell-intrinsic changes 
influence the aged immune system.
Mature B cells in the aging immune system
In addition to developmental impairment, mature peripheral B cells display altered 
maintenance and function in the aged immune system. Aged mice display a decrease in B 
cell diversity46,47 and an increase in long-lived B cells,43 which, in a transgenic model 
favoring selection, have been shown to be the result of an increase in antigen-experienced B 
cells.48 Despite the decrease in pro-B, pre-B, and immature B cell subsets, the number of FO 
B cells is only slightly decreased in aged animals.49 In the case of MZ B cells, a significant 
decrease has been demonstrated in aged mice as compared to the young.50 Furthermore, the 
aged splenic environment causes a decrease in migration of immature and MZ B cells.51 
However, with advancing age, there is an increase in a subset of B cells termed age-
associated B cells (ABCs), which are found in both the spleen and BM.52 These B cells are 
shown to arise from exhaustively expanded mature B cells. Interestingly, ABCs produce 
TNF-α, which has been shown to induce apoptosis in pro-B cells.53 It is still not clear if the 
cell-intrinsic and cell-extrinsic changes occurring during early B development are the 
initiating factors leading to the increase in peripheral B cell longevity, which then 
propagates the decrease in B cell development, or if the long-lived peripheral B cells 
initiated the decrease in B lymphopoiesis. Regardless, the changes in B cell development 
(described above) and peripheral B cell characteristics may lead to the decreased repertoire 
diversity observed in aged B cells.
Responses to antigens and the ability to produce effective antibodies are defective in the 
aged immune system. B cells produce high-affinity antibodies within the germinal center 
(GC), where antibodies undergo affinity maturation and somatic hypermutation. However, 
there is a decrease in the number and volume of GCs formed in aged mice.54 In addition, 
aged mice display reduced somatic hypermutation (SHM), reduced class-switch 
recombination (CSR), and decreased AID expression, which is required for both SHM and 
CSR.30 Interestingly, E2A expression is also decreased in aged mature splenic B cells and is 
required for AID expression.30 Therefore, mature B cells from aged mice have defects in the 
mechanisms used to generate effective antibodies. These defects may have consequences 
upon generation of antibodies for diseases affecting the elderly such as S. pneumoniae 
infection.
After immunization of old mice, the amount of antibody produced is not always changed, 
but the affinity to the specific antigen is severely decreased.55 This has been shown to be the 
case for the pneumoccal vaccine in the elderly.56 The B cell repertoire pre- and 
postimmunization is also different in aged mice. In the case of antibodies to 
phosphorylcholine (PC), a cell wall epitope of S. pneumoniae, older mice show usage of a 
variety of VH genes other than the restricted VH1 utilized by the T15 idiotype of younger 
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mice.46 Significantly, these anti-PC antibodies found in older mice have been shown to be 
less protective than the T15 idiotype found in young mice.57,58 Together, these studies 
suggest that immunization in the aged does not elicit the generation of protective antibodies. 
Consequently, the aged individual is dependent upon natural IgM and/or previously formed 
memory for protection against S. pneumoniae infection. At the time of these reports, much 
of B-1 cell biology was unknown. Therefore, many of these differences observed in aged 
mice are still not fully understood. Today, we are able to precisely collect and study various 
subsets of B-1 cells, and it has been clearly demonstrated that B-1a cells are required to clear 
S. pneumonia.59 Thus, although we now know B-1a cells are essential for the maintenance 
of health, the role B-1a cells play in the aging immune system has yet to be fully 
investigated.
B-1 cells: essential protective role in diseases of the elderly
Role of B-1–derived natural IgM
B-1a cells are phenotypically characterized by cell surface markers: CD5+ IgMhigh IgDlow 
B220low MAC-1+ CD23− CD43+.60 B-1 cells residing in the BM and spleen produce 80% of 
the natural, non-immune serum IgM in mice.17 Natural IgM is non-immune, polyreactive, 
low-affinity immunoglobulin (Ig) that functions in infection, atherosclerosis, B cell 
homeostasis, inflammation, and autoimmunity (reviewed in Ref. 61). It is able to bind 
conserved structures, sometimes more than one, on organisms, and thereby neutralize and 
facilitate the removal of such infectious agents. The unique ability of natural antibodies to 
play this essential role in the immune system is afforded by their structure, both in the 
constant and variable regions. IgM is mainly in the pentameric form, which effectively binds 
the complement component C1q and is important for both the clearance of pathogens and 
removal of apoptotic cells.61 Natural IgM produced by B-1 cells is also germ line like, as 
evidenced by the relative lack of N-region additions, and has a more restricted repertoire.62 
B-1 cell–derived natural IgM is essential for (1) controlling bacterial and viral infections,17 
(2) aiding in the elimination of excess autoantigens that are increased in the elderly through 
removal of apoptotic cells,61 and (3) binding oxidized low-density lipoprotein (OxLDL), in 
particular by antibodies bearing the T15 idiotype, which helps control the inflammatory 
process leading to atherosclerotic plaques.7 Given these functions, B-1 cell–derived natural 
antibody has been shown to play essential protective roles in two diseases that significantly 
affect the elderly, S. pneumoniae infection and atherosclerosis.
Due to the germ line–like Ig and restricted repertoire, B-1 cell–derived natural IgM is 
evolutionarily conserved, which affords its ability to control bacterial infections. IgM 
produced by B-1 cells recognizes phosphatidylcholine (PtC) and other discrete microbial 
cell wall determinates such as PC from S. pneumoniae. In particular, anti-PC antibody 
derived from B-1a cells has been well characterized and shown to be protective against S. 
pneumoniae infection.59,63 The importance of anti-PC and anti-pneumococcal capsular 
polysaccharide 3 (PPS3) germ line–like natural antibodies was shown in mice lacking B-1a 
cells, as they were unable to survive acute infection with S. pneumonia.59 N-addition has 
been shown to play a key role in antigen receptor diversity and antibody effectiveness to 
certain pathogens. The prototypical B-1a anti-PC antibody, T15, has no N-addition.63,64 
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Remarkably, TdT transgenic mice vaccinated with heat-killed S. pneumoniae generated an 
anti-PC response, but these anti-PC antibodies were not protective against S. pneumoniae 
infection.65 This study demonstrates that the increased diversity generated by N-addition can 
be detrimental for microbial protection, and highlights the importance of structure in the 
protection provided by evolutionarily conserved natural antibody.
Anti-PC natural antibody, in particular T15, has also been shown to be protective in 
atherosclerosis. Natural antibodies to OxLDL have been observed in healthy individuals 
over the age of 10066 and in healthy mice, and were subsequently shown to be identical to 
the anti-PC T15 clone.67 Interestingly, when atherosclerosis-prone mice were injected with 
heat-killed S. pneumonia, they exhibited high levels of serum anti-OxLDL IgM and reduced 
atherosclerosis.68 More recently, it has been demonstrated that mice deficient in secretory 
IgM or C1q develop increased atherosclerotic lesions as compared to mice with serum IgM 
or C1q.61,69 It has also been shown that treatment of mice that have advanced 
atherosclerosis with natural IgM reduces disease and increases anti-OxLDL levels.70 In 
accordance with these studies, it has been demonstrated that B-1a cells and B-1a cell–
derived natural IgM are protective against atherosclerosis.8 Together, these studies establish 
a protective role for natural antibodies and B-1a cells in atherosclerosis.
B-1 cells’ unique ability to produce protective natural IgM: a role for development
As mentioned above, the B-1 cell population originates during fetal life and persists 
throughout adult life through self-renewal.71–73 More recently, it was demonstrated that the 
B-1 cell–specific progenitor (B1P), AA4.1+Lin−CD45Rlow/−CD19+, is found in both the 
fetal liver (FL) and adult BM.18 Other groups have also independently shown that total 
lineage-negative BM can give rise to B-1a cells.74–76 During fetal development, the enzyme 
mediating increased junctional diversity by way of N-region additions, TdT, is not 
expressed.77 This lack of TdT expression during fetal life allows natural germ line–like 
antibodies to develop lacking N-additions. Presumably, different selection pressures during 
fetal life also contribute to the development of these protective natural antibodies. We have 
recently demonstrated that transfer of fetal liver B1P into adult SCID mice produces B-1a 
cell IgM with few N-additions; however, transfer of the BM B1P into adult SCID mice 
produces B-1a cell IgM with abundant N-additions.78 In accordance with these results, 
assessment of TdT gene expression revealed high levels of TdT in the B1P from the adult 
BM and no expression in the B1P from FL. However, upon transfer of 
AA4.1−Lin−CD45R−CD19− fetal liver cells into adult SCID mice, we found that B-1a cells 
originating from this population produced IgM with abundant N-additions, despite the lack 
of TdT expression. The mechanism for this is still unclear, but suggests that 
AA4.1−Lin−CD45R−CD19− fetal liver cells may contain cells that, once in the BM, 
differentiate into AA4.1+Lin−CD45Rlow/−CD19+ cells (B1P) and acquire TdT. This 
hypothesis would fit well with previous reports demonstrating that HSCs and CLPs from 
adult BM are inefficient at generating B-1a cells.79,80 Interestingly, fetal liver and neonatal 
HSCs efficiently generate B-1a cells. The reason for this discrepancy is still not understood, 
but it is hypothesized that changes in the hematopoietic environment play a role (reviewed 
in Ref. 81). Together, these results demonstrate that the unique developmental environment 
in which B-1 cells derive plays a role in the generation of protective natural IgM. However, 
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much of how this development is maintained throughout adulthood and into old age is 
unknown.
B-1 cells in the aging immune system
Despite the number of years B-1 cells have been studied, there is a large gap in our 
knowledge about B-1 cell biology in the aged. The most well-known feature of B-1 cells in 
the aging immune system is their general expansion.82 There is an increase in the number of 
anti-PC B cells in adult mice with age; however, these anti-PC antibodies were shown to 
originate from newly generated BM B cells and do not have the canonical T15 idiotype.46 
This difference in VH usage would be predicted since these newly generated anti-PC B cells 
are not being generated during fetal life. Furthermore, studies have demonstrated that non-
T15 anti-PC antibodies are less protective.46,65 Changes in repertoire with age have also 
been demonstrated for the quintessential B-1 cell specificity, PtC, which utilizes VH11, 
VH12, and Q52 (VH2). It has been shown that aged splenic B cells utilize the variable 
heavy chains VH11 and Q52 more often than splenic B cells from young mice.47 However, 
another study demonstrated a selective increase in VH12 and not VH11 usage in peritoneal 
B-1 cells with increasing age.83 Interestingly, B-1 cells obtained from aged mice have also 
been shown to produce antibody with abundant N-additions.74,84 Together, these findings 
have stimulating implications for B-1 cell maintenance with age.
As described above, BM-derived (BMD) B-1a cells have abundant N-region additions and 
do not express the same level of repertoire skewing as fetal liver–derived B-1a cells.74 
Furthermore, native B-1a cells from aged mice contain more N-region additions than those 
from young mice.74,84 It has also been shown that the number of BM B-1 cell progenitors 
does not change with age.85 Together, these results suggest that adult BM progenitors could 
contribute to the B-1a cell pool over time, thereby changing the spontaneously secreted 
germ line–like IgM shown to be required for immediate protection against S. pneumoniae 
infection and atherosclerosis. From these studies, we hypothesize that the level of natural 
IgM protection changes with age as a result of functional and/or repertoire-associated 
alterations to the B-1a cell pool over time. However, many studies are needed to fill in the 
large gap in our knowledge of B-1 cell biology with increasing age.
Future focus: innate B cells in aging
Clearly, B-1 cell natural antibody plays an essential role in protection from S. pneumoniae 
infection and atherosclerosis. Nevertheless, our understanding of how this essential arm of 
the immune system changes with age is greatly lacking. Our knowledge about B-1 cells has 
grown exponentially to define new subsets and functions and a specific progenitor, and it 
even extends to defining a human equivalent (reviewed in Ref. 86). In addition, our 
understanding of how natural IgM is secreted and which subsets secrete natural antibody has 
been refined.87–89 However, we are clearly lacking in understanding how B-1a cell 
development, different subsets, and functions are affected by the aging process. Careful 
consideration should also be taken of the strain and sex of the mice analyzed. In our own 
studies, we have found no expansion of B-1 cells in aged male mice, but preliminary results 
suggest expansion in female mice (unpublished observations). Along these lines, diet and 
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SPF status might also influence aging studies of mice. Building upon the model set forth by 
Dorshkind and Montecino-Rodriguez, we suggest possible mechanisms leading to B-1 cell–
derived IgM with abundant N-additions with age based on the current literature (Fig. 3). 
This is just a speculative model, and we anticipate that with more research, especially 
research focused on maintenance and aging, the precise mechanisms will be worked out. 
Understanding these mechanisms will most certainly provide the necessary insight to 
improve the health of the aging population.
Conclusions
The B-1a cell population is capable of producing antibodies that provide immediate 
protection against S. pneumoniae and confer protection against atherosclerosis in young 
mice. While much is known about conventional B-2 cell subsets, the B-1 cell subset has not 
been well studied in aged mice to date. Such studies directed at understanding the biology of 
this unique B cell subset in aged mice will greatly improve our ability to design preventative 
strategies and/or treatments of S. pneumoniae infection in the elderly. In addition, the natural 
antibodies produced by B-1a cells help reduce the onset of atherosclerosis.90,91 Therefore, 
the knowledge gained from further study will not only aid in understanding of this protective 
B cell subset for preventative strategies and/or treatments of S. pneumoniae infection but 
also will further our knowledge of therapeutic strategies for atherosclerosis.
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B cell development. B cell development begins with hematopoietic stem cells (HSCs) and 
continues through a series of differentiation steps dictated by expression of transcription 
factors, cytokines, and cell surface receptors. Long-term repopulating HSCs (LT-HSCs) and 
short-term HSCs (ST-HSCs) are named for their capacity to self-renew. The HSCs first 
differentiate into multipotential progenitors (MPP). Upon signaling through Flt-3, the MPPs 
differentiate into lymphoid-primed multipotential progenitors (LMPP), which differentiate 
into common lymphoid progenitors (CLP) upon Flt-3 and IL-7 signaling. Induction of the 
transcription factors E2A and EBF mark the differentiation of the CLP into a pre-pro B cell, 
commonly referred to as fraction A. E2A and EBF allow immunoglobulin rearrangement to 
begin, which is necessary for the development of B cells. Proper immunoglobulin 
rearrangement allows for the B cell to progress though each stage of differentiation, ending 
in a naive B cell, which can migrate into the periphery. Each stage of B cell development is 
marked by specific gene expression and surface marker expression as shown.
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The aged developing and mature B cell pools. Both cell-intrinsic and cell-extrinsic changes 
occur throughout the stages of B cell development ranging from pre-lymphoid commitment 
(HSCs) to immature B cells. The mature B-2 cell pool in aged mice consists of follicular 
(FO) B cells, marginal zone (MZ) B cells, and age-associated B cells (ABC). Black arrows 
depict the relative increase or decrease in the differentiation subsets leading to mature B cell 
development. The asterisk (*) above fraction B/C denotes additional changes in the cells in 
the aged, which include decreased RAG and E2A expression.
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B-1 cell development and maintenance with age. Building upon the model proposed by 
Motecino-Rodriguez and Dorshkind,81 we add what is currently known about the distinct 
waves of B-1 cell development leading to an adult pool of B-1a cells and propose extending 
the model to encompass changes with increasing age. (1) During the first wave of 
development, B-1 cell progenitors (AA4.1+Lin−CD45Rlow/−CD19+) are derived from yolk 
sac (YS) and para-aortic splanchnopleura (PSp) endothelium,92 before the emergence of 
HSCs. Whether this first wave of B-1 cells contributes to the adult pool of B-1 cells is still 
being examined. (2) The fetal liver and bone marrow is the site of the second wave of 
development. Current data has shown that HSCs are capable of giving rise to B-1 cells 
during fetal life, whereas HSCs present in the adult bone marrow are significantly less 
efficient at producing B-1 cells.79 It is not yet known whether HSCs have specified 
differentiation potential or if they lose their potential to produce B-1 cells in the adult. To 
indicate these possibilities, we have chosen a different color for HSCs producing B-1 cells 
during fetal life (green) versus those giving rise to B-2 cells (gray), which have limited 
development during fetal life. It has been shown that there is commitment to either B-1 or 
B-2 lineage at the CLP stage.81 Our recent results demonstrate that 
AA4.1−Lin−CD45R−CD19− fetal liver cells (NEG, light green circles) give rise to B-1 cells 
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with increased diversity (abundant N-additions) upon transfer into adult SCID mice, 
whereas transfer of the fetal liver–derived B-1 cell progenitors 
(AA4.1+Lin−CD45Rlow/−CD19+) into adult SCID mice yields B-1 cells with limited N-
region additions. These results suggest that an earlier population may differentiate into B-1 
cell progenitors giving rise to more than one type of B-1 cell progenitor (red circle versus 
light blue circles), although whether this happens physiologically is not known. Either way, 
B-1 cells that develop during fetal and neonatal life have limited N-additions. (3) The third 
wave of development occurs in the adult bone marrow and mainly yields B-2 cells. We 
hypothesize that a possible mechanism of non-HSC–dependent B-1 cell development during 
adult life might occur via the NEG population of fetal liver cells that have migrated to the 
adult bone marrow. Furthermore, this adult development of B-1 cells would produce B-1 
cells with increased N-additions, contributing to the change in B-1 cell –derived natural IgM 
with age.
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